Assignee: Yissum Research Development Company

Location: Jerusalem, IL
No. of patents: 22

Number	Title	Issue Date
7759526	Pharmaceutical compositions comprising cannabidiol derivatives The present invention relates to cannabidiol derivatives and to pharmaceutical compositions comprising cannabidiol derivatives being antiinflammatory agents having analgesic, antianxiety, anticonvulsive, neuroprotective, antipsychotic and anticancer activity.	07/20/2010
6926913	Composition containing molecular iodine The invention provides a composition of matter comprising molecular iodine and tetraglycol. ...	08/09/2005
6908764	Recombinant human cell for bone and cartilage cell formation The invention relates to a recombinant human cell of undifferentiated mesenchyma for bone and cartilage cell formation, the human cell having the ability to express Tbr-1, Brachyury or another member of the T-box family. ...	06/21/2005
6891925	Method to determine the three-dimensional atomic structure of molecules The invention presents an x-ray method for determining the three-dimensional molecular structure of molecules having an unknown structure. The molecules having unknown structure are arranged in a two-dimensional periodic array on a substrate molecular crystal having...	05/10/2005
6656460	Method and composition for dry eye treatment A method and composition for treating a dry eye condition by topically applying to the eye surfaces an emulsion forming a tear film that acts to lubricate the eye and to inhibit evaporation therefrom. The emulsion is constituted by water in which is dispe...	12/02/2003
6562424	Photochemical sensors and method for the production thereof The invention provides an indicator dye nanoporous photochemical sensor composite glass film, comprising a multiplicity of polyacrylate chains intertwined with a multiplicity of cross-linked networks of silica and doped with an indicator dye, wherein the ...	05/13/2003
6323023	Vectors containing nucleic acids coding for Arabidopsis thaliana endo-1,4-ଲ-glucanase secretion signal peptide The present invention discloses genetically engineered plants which display altered structure or morphology. The transgenic plants express a cell wall modulation transgene or gene construct that results in the altered structure or morphology. The altered ...	11/27/2001
6258780	Method and composition for enabling passage through the blood-brain-barrier A pharmaceutical composition for facilitating passage of compounds through the blood-brain barrier comprising the agent ACHE-I4 readthrough (SEQ ID No:1) splice variant or the I4 peptide (SEQ ID No:2) and analogues of each thereof and a pharmaceutically a...	07/10/2001
6052124	System and method for directly estimating three-dimensional structure of objects in a scene and camera motion from three two-dimensional views of the scene A scene reconstruction system generates a reconstruction of at least one feature of at least one three-dimensional object in a scene from three two-dimensional views as recorded from a plurality of diverse locations. The scene reconstruction system includ...	04/18/2000
6037151	Process for the preparation of long-chain alkyl glycosides The invention provides a process for the preparation of long-chain alkyl glycosides, comprising reacting a glucose-containing reactant and a C8 -C18 fatty alcohol in the presence of a glucosidase and a reaction promoter effective to ...	03/14/2000
5776970	Tryptophan derivatives as protein tyrosine kinase blockers and their use in the treatment of neoplastic diseases Tryptophan derivatives substituted by a hydrophobic group, e.g. carbobenzoxy, at the N-terminus, and a hydrophilic group, e.g. --COOH, --SO3 H or --PO3 H, at the C-terminus, were found to be cell-permeable blockers of protein tyrosin...	07/07/1998
5763441	Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction and particularly KDR/FLK-1 receptor signal transduction in order to regulate and/or modulate vasculogenesis and angiogenesis. The invention is bas...	06/09/1998
5712395	Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction and particularly KDR/FLK-1 receptor signal transduction in order to regulate and/or modulate vasculogenesis and angiogenesis. The invention is bas...	01/27/1998
5538993	Certain tetrahydrocannabinol-7-oic acid derivatives The invention relates to compounds of the formula ##STR1## having the (3S,4S) configuration and being essentially free of the (3R,4R) enantiomer, in which A--B indicates an optional 1(2) or 6(1) double bond, X is carboxy, carbalkoxy, or carboxamido, ...	07/23/1996
5518736	Method of preparing natural-oil-containing emulsions and microcapsules and its uses The invention relates to sustained-release biodegradable lice repelling preparations comprising as active ingredient a lice repelling agent comprising at least one natural oil selected from the group consisting of citronella oil, rosemary oil and eucalypt...	05/21/1996
5434295	Neuroprotective pharmaceutical compositions of 4-phenylpinene derivatives and certain novel 4-phenylpinene compounds The present invention provides certain novel 4-phenylpinene derivatives, and teaches how to use said novel derivatives and related compounds in pharmaceutical compositions that have utility in treating various pathological conditions associated with damag...	07/18/1995
5387576	Treatment of hyperproliferative epidermal conditions with activin A Pharmaceutical preparations for the treatment of hyperproliferative epidermal conditions comprising the specific negative growth factor activin A, and their use in methods of treatment of hyperproliferative epidermal conditions....	02/07/1995
4826945	Biodegradable polymeric materials based on polyether glycols, processes for the preparation thereof and surgical articles made therefrom The invention provides poly(଱-hydroxy-carboxylic acid)/poly(oxyalkylene) polymers selected from multiblock polymers of the following repeating unit I ##STR1## wherein R is an alkylene group, R1 is hydrogen or methyl groups, m is ...	05/02/1989
4792625	Process for the reduction of organic compounds using alkali formate salts The invention provides a process for reducing substantially water insoluble organic compounds containing reducible groups comprising contacting these compounds with an aqueous solution of a formic acid salt in the presence of a hydrogenation catalyst and ...	12/20/1988
4773430	Method and apparatus for the localization of bleeding in the gastrointestinal tract The present invention relates to a method for the localization of bleeding in the gastrointestinal tract. More particularly, the present invention relates to a method wherein gastric or intestinal contents at different locations in the gastrointestinal tr...	09/27/1988
4273757	Determination of transcobalamins A process and test kit for the quantitative determination of the individual and total unsaturated Vitamin B-12 binding capacities of the three transcobalamins TC-I, TC-II, and TC-III in serum. The process comprises incubating a serum sample with a solutio...	06/16/1981
3961894	Test for determination of triiodothyronine A radioimmunoassay method for the determination of triiodothyronine in human and animal fluids and tissues, particularly in serum. The method involves the separation of triiodothyronine from its binding proteins using a dextran gel column followed by comp...	06/08/1976

PatentStorm

Quotables

PatentStorm News

Assignee: Yissum Research Development Company